Publications by authors named "Prem Seth"

Claim this Profile
O
Oncolytic adenovirus encoding LIGHT (TNFSF14) inhibits tumor growth via activating anti-tumor immune responses in 4T1 mouse mammary tumor model in immune competent syngeneic mice.
Shiyun Dai, Yun Lv, Weidong Xu, Yuefeng Yang, Chao Liu, Prem Seth

Cancer Gene Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure and mechanical behavior of developed MgSi phase in magnesium and aluminum alloys - a review.
Prem Prakash Seth, Om Parkash, Devendra Kumar

RSC Adv· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Oncolytic Viruses and Cancer Immunotherapy.
Prem Seth

Hum Gene Ther· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Oncolytic Viruses and Cancer Immunotherapy.
Prem Seth

Hum Gene Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor β Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models.
Weidong Xu, Yuefeng Yang, Zebin Hu, Maria Head, Kathy A Mangold, Donald L Helseth, Prem Seth

Hum Gene Ther· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Oncolytic Viruses and Cancer Immunotherapy.
Prem Seth

Hum Gene Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic adenovirus targeting TGF-β enhances anti-tumor responses of mesothelin-targeted chimeric antigen receptor T cell therapy against breast cancer.
Yuxiang Li, Fengjun Xiao, Aimei Zhang, Dan Zhang, Wenbo Nie, Prem Seth

Cell Immunol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy.
Yuefeng Yang, Weidong Xu, Di Peng, Hao Wang, Xiaoyan Zhang, Donald L Helseth, Prem Seth

Hum Gene Ther· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic Adenovirus rAd.DCN Inhibits Breast Tumor Growth and Lung Metastasis in an Immune-Competent Orthotopic Xenograft Model.
Huiqiang Zhao, Hao Wang, Fanxuan Kong, Weidong Xu, Tao Wang, Prem Seth

Hum Gene Ther· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decorin-Modified Umbilical Cord Mesenchymal Stem Cells (MSCs) Attenuate Radiation-Induced Lung Injuries via Regulating Inflammation, Fibrotic Factors, and Immune Responses.
Daming Liu, Fanxuan Kong, Yong Yuan, Prem Seth, Weidong Xu

Int J Radiat Oncol Biol Phys· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation.
Zhao Liu, Yuefeng Yang, Xiaoyan Zhang, Hao Wang, Weidong Xu, Prem Seth

Hum Gene Ther· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SUMO-Specific Cysteine Protease 1 Promotes Epithelial Mesenchymal Transition of Prostate Cancer Cells via Regulating SMAD4 deSUMOylation.
Xiaoyan Zhang, Hao Wang, Hua Wang, Fengjun Xiao, Prem Seth

Int J Mol Sci· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Delivery of an Oncolytic Adenovirus Expressing Decorin for the Treatment of Breast Cancer Bone Metastases.
Yuefeng Yang, Weidong Xu, Thomas Neill, Zebin Hu, Chi-Hsiung Wang, Prem Seth

Hum Gene Ther· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ad5/48 hexon oncolytic virus expressing sTGFβRIIFc produces reduced hepatic and systemic toxicities and inhibits prostate cancer bone metastases.
Weidong Xu, Zhenwei Zhang, Yuefeng Yang, Zebin Hu, Chi-Hsiung Wang, Prem Seth

Mol Ther· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA regulation of oncolytic adenovirus 6 for selective treatment of castration-resistant prostate cancer.
Zhenwei Zhang, Xuemei Zhang, Kam Newman, Xinyuan Liu, Prem Seth

Mol Cancer Ther· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic delivery of oncolytic adenoviruses targeting transforming growth factor-β inhibits established bone metastasis in a prostate cancer mouse model.
Zebin Hu, Janhavi Gupta, Zhenwei Zhang, Helen Gerseny, Arthur Berg, Prem Seth

Hum Gene Ther· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic delivery of a novel liver-detargeted oncolytic adenovirus causes reduced liver toxicity but maintains the antitumor response in a breast cancer bone metastasis model.
Zhenwei Zhang, Jeffrey Krimmel, Zhiling Zhang, Zebin Hu, Prem Seth

Hum Gene Ther· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic adenovirus expressing soluble TGFβ receptor II-Fc-mediated inhibition of established bone metastases: a safe and effective systemic therapeutic approach for breast cancer.
Zebin Hu, Helen Gerseny, Zhenwei Zhang, Yun-Ju Chen, Arthur Berg, Prem Seth

Mol Ther· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGFβ-dependent induction of interleukin-11 and interleukin-8 involves SMAD and p38 MAPK pathways in breast tumor models with varied bone metastases potential.
Janhavi Gupta, John Robbins, Tamas Jilling, Prem Seth

Cancer Biol Ther· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic delivery of an oncolytic adenovirus expressing soluble transforming growth factor-β receptor II-Fc fusion protein can inhibit breast cancer bone metastasis in a mouse model.
Zebin Hu, Zhenwei Zhang, Theresa Guise, Prem Seth

Hum Gene Ther· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biology of breast cancer bone metastasis.
Mojtaba Akhtari, Junaid Mansuri, Kam A Newman, Theresa M Guise, Prem Seth

Cancer Biol Ther· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating apoptosis in tumor cells infected with adenovirus expressing p53 tumor suppressor gene.
Elizabeth Perron, M Behzad Zafar, Amanda Pister, Zhen-Guo Wang, Jun Tian, Prem Seth

Methods Mol Med· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of oncolytic adenovirus armed with a fusion of soluble transforming growth factor-beta receptor II and human immunoglobulin Fc for breast cancer therapy.
Prem Seth, Zhen-Guo Wang, Amanda Pister, M Behzad Zafar, Sung Kim

Hum Gene Ther· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An oncolytic adenovirus expressing soluble transforming growth factor-beta type II receptor for targeting breast cancer: in vitro evaluation.
Zhen-Guo Wang, Wenli Zhao, Murali Ramachandra, Prem Seth

Mol Cancer Ther· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vector-mediated cancer gene therapy: an overview.
Prem Seth

Cancer Biol Ther· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis